{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-079602","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.145446+00:00","generated_at":"2026-05-31T23:58:34.002474+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Arcadia Biosciences stockholders approve all four proposals at 2024 annual meeting","bullets":["Amy Yoder elected with 160,017 votes for; Lilian Shackelford Murray with 149,613 for; 501,220 broker non-votes.","Ratification of Deloitte & Touche as auditors for FY 2024: 666,133 for, 13,547 against, 2,913 abstain.","Amendment to 2015 Omnibus Equity Incentive Plan approved: 120,214 for, 60,507 against, 652 abstain, 501,220 broker non-votes.","Advisory vote on executive compensation approved: 153,487 for, 27,183 against, 703 abstain, 501,220 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-079602","json":"https://secwatch.observer/filing/0000950170-24-079602.json","markdown":"https://secwatch.observer/filing/0000950170-24-079602.md","text":"https://secwatch.observer/filing/0000950170-24-079602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024079602/0000950170-24-079602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024079602/rkda-20240625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:58:34.002474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}